Cargando…
The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review
Background: The role of denosumab in patients with resectable giant cell tumour of bone remains unclear. We asked the following research question: for patients (aged ≥ 12 years) with resectable giant cell tumour of bone, what are the benefits and harms of denosumab compared with no denosumab in term...
Autores principales: | Gupta, Abha, Durocher-Allen, Lisa, Popovic, Snezana, Tozer, Richard, Yao, Xiaomei, Ghert, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025825/ https://www.ncbi.nlm.nih.gov/pubmed/33809979 http://dx.doi.org/10.3390/curroncol28020124 |
Ejemplares similares
-
Radiological findings of denosumab treatment for giant cell tumours of bone
por: van Langevelde, Kirsten, et al.
Publicado: (2020) -
AP-1 as a Regulator of MMP-13 in the Stromal Cell of Giant Cell Tumor of Bone
por: Mak, Isabella W. Y., et al.
Publicado: (2011) -
Giant cell tumour of bone in os sacrum of a prepubertal girl – Surgical and medical treatment with zoledronate and denosumab
por: Beck-Nielsen, Signe Sparre, et al.
Publicado: (2023) -
The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone
por: Weschenfelder, Wolfram, et al.
Publicado: (2021) -
Surgical challenges, novel techniques, and systemic treatment of giant cell tumour of bone of the distal radius: clinical outcomes and systematic review of the literature
por: van der Heijden, Lizz, et al.
Publicado: (2022)